Department of Medical Specialties I and III, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, Cardiovascular and Respiratory Rehabilitation Clinic, Pantelimon Halipa Street No. 14, 700661 Iasi, Romania.
Medicina (Kaunas). 2023 Dec 27;60(1):51. doi: 10.3390/medicina60010051.
: Assessment of the prothrombotic, proinflammatory, and functional status of a cohort of COVID-19 patients at least two years after the acute infection to identify parameters with potential therapeutic and prognostic value. : We conducted a retrospective, descriptive study that included 117 consecutive patients admitted to Iasi Pulmonary Rehabilitation Clinic for reassessment and a rehabilitation program at least two years after a COVID-19 infection. The cohort was divided into two groups based on the presence ( = 49) or absence ( = 68) of pulmonary fibrosis, documented through high-resolution computer tomography. : The cohort comprises 117 patients, 69.23% females, with a mean age of 65.74 ± 10.19 years and abnormal body mass index (31.42 ± 5.71 kg/m). Patients with pulmonary fibrosis have significantly higher levels of C-reactive protein (CRP) ( < 0.05), WBC (7.45 ± 7.86/mm vs. 9.18 ± 17.24/mm, = 0.053), neutrophils (4.68 ± 7.88/mm vs. 9.07 ± 17.44/mm, < 0.05), mean platelet volume (MPV) (7.22 ± 0.93 vs. 10.25 ± 0.86 fL, < 0.05), lactate dehydrogenase ( < 0.05), and D-dimers ( < 0.05), but not ferritin ( = 0.470), reflecting the chronic proinflammatory and prothrombotic status. Additionally, patients with associated pulmonary fibrosis had a higher mean heart rate ( < 0.05) and corrected QT interval ( < 0.05). D-dimers were strongly and negatively correlated with diffusion capacity corrected for hemoglobin (DLCO corr), and ROC analysis showed that the persistence of high D-dimers values is a predictor for low DLCO values (ROC analysis: area under the curve of 0.772, < 0.001). The results of pulmonary function tests (spirometry, body plethysmography) and the 6-minute walk test demonstrated no significant difference between groups, without notable impairment within either group. Patients with COVID-19-related pulmonary fibrosis have a persistent long-term proinflammatory, prothrombotic status, despite the functional recovery. The persistence of elevated D-dimer levels could emerge as a predictive factor associated with impaired DLCO.
评估至少在 COVID-19 急性感染后两年的 COVID-19 患者的血栓形成前、促炎和功能状态,以确定具有潜在治疗和预后价值的参数。
我们进行了一项回顾性描述性研究,纳入了 117 例连续患者,这些患者在感染 COVID-19 至少两年后,因肺康复诊所评估和康复计划而入院。该队列根据是否存在(= 49)或不存在(= 68)通过高分辨率计算机断层扫描记录的肺纤维化分为两组。
该队列包括 117 例患者,女性占 69.23%,平均年龄为 65.74 ± 10.19 岁,体重指数异常(31.42 ± 5.71 kg/m)。肺纤维化患者的 C 反应蛋白(CRP)水平显著升高(< 0.05)、白细胞计数(WBC)(7.45 ± 7.86/mm 与 9.18 ± 17.24/mm,= 0.053)、中性粒细胞(4.68 ± 7.88/mm 与 9.07 ± 17.44/mm,< 0.05)、平均血小板体积(MPV)(7.22 ± 0.93 vs. 10.25 ± 0.86 fL,< 0.05)、乳酸脱氢酶(< 0.05)和 D-二聚体(< 0.05),但铁蛋白无差异(= 0.470),反映出慢性促炎和血栓形成前状态。此外,伴有肺纤维化的患者心率均值较高(< 0.05)和校正 QT 间期(< 0.05)较高。D-二聚体与血红蛋白校正弥散量(DLCO corr)呈强烈负相关,ROC 分析表明高 D-二聚体值的持续存在是低 DLCO 值的预测因素(ROC 分析:曲线下面积为 0.772,< 0.001)。肺功能检查(肺活量测定、体描法)和 6 分钟步行试验的结果表明两组间无显著差异,两组均无明显功能障碍。尽管功能恢复,但 COVID-19 相关肺纤维化患者仍存在持续的长期促炎、血栓形成前状态。D-二聚体水平升高的持续存在可能成为与 DLCO 受损相关的预测因子。